Boston Scientific Corporation (BSX) CEO Michael Mahoney on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 07/29/20
Boston Scientific swings to loss and sales fall, but remain ahead of estimatesMarket Watch • 07/29/20
Beyond COVID-19, Credit Suisse Shows Its Top Health Care Recovery Stock Picks24/7 Wall Street • 07/28/20
Earnings Preview: Boston Scientific (BSX) Q2 Earnings Expected to DeclineZacks Investment Research • 07/22/20
Boston Scientific Receives FDA Approval for Next-Generation WATCHMAN FLX™ Left Atrial Appendage Closure DevicePRNewsWire • 07/21/20
Why These Top Medical Device Stocks Have Fallen by Double Digits So Far in 2020The Motley Fool • 07/11/20
Boston Scientific Receives FDA 510(k) Clearance for the LUX-Dx™ Insertable Cardiac Monitor SystemPRNewsWire • 06/29/20
Boston Scientific Receives Medicare Transitional Pass-Through Payment for the EXALT™ Model D Single-Use DuodenoscopePRNewsWire • 06/08/20
Boston Scientific Corporation (BSX) Management Presents at Jefferies 2020 Virtual Healthcare Conference (Transcript)Seeking Alpha • 06/02/20